Company News

In traditional industrial manufacturing, this question is often answered with a resounding ‘yes’. Overall Equipment Effectiveness (OEE) is regarded there as a key performance indicator, with the focus on high capacity utilisation and the continuous production of homogeneous batches. However, the operating conditions in the pharmaceutical industry place this perspective within a broader context. The…

Interview. Christoph Reinwald, General Manager of Complex Pharmaceuticals: a conversation about supply security, new thinking in pharmaceutical production, corporate culture and leadership. Mr Reinwald, ensuring the supply of pharmaceutical products has increasingly become a challenge in Europe and in Austria in recent years. What is causing this, and what needs to change? The causes are…

PharmaPharma start-up welcomes seasoned networker on board: Pharmaceutical start-up Complex Pharmaceuticals is taking another strategic step in building the company: Jürgen Fuchs (44) has joined the team on 1 April 2026. As Head of Partner Management, he is responsible for establishing and continuously expanding the contract client network. Drawing on his extensive experience in pharmaceutical…

Establishing a pharmaceutical company at a high-cost location such as Austria sometimes raises questions. From Complex Pharmaceuticals’ perspective, the answer lies in the changed requirements for supply security, quality and technological independence within the European pharmaceutical industry. Recent years have clearly demonstrated how deeply interconnected global supply chains are, and how important robust, regionally anchored…

The requirements placed on the pharmaceutical industry have changed significantly in recent years. Supply security, regulatory stability and resilient supply chains are increasingly coming into focus. Against this backdrop, the development of regional production and logistics expertise within Europe is gaining in importance. Complex Pharmaceuticals was founded with the goal of implementing industrial processes along…

Sustainability is gaining increasing importance in the pharmaceutical industry as well. In a highly regulated environment shaped by GMP requirements, product safety and process stability, the focus is primarily on technically sound and economically viable solutions. Complex Pharmaceuticals therefore regards ecological responsibility as an integral component of efficient production and packaging processes. The aim is…

The pharmaceutical industry makes substantial investments in GMP-compliant production areas, automation and digital systems. However, as technological standardisation increases, the differentiation between sites is shifting. Against this backdrop, the question arises as to which factors contribute to resilience against external influences such as skills shortages, regulatory pressure and market changes. Alongside technical equipment, leadership models…

In pharmaceutical development, the focus is frequently on active ingredient research and clinical development. This orientation is systemically understandable. At the end of the value chain, however, secondary packaging acts as a connecting element between product development and market access, and influences the transfer into different markets. Increasing structural complexityAs modern therapies advance, particularly in…

Supply shortages of pharmaceutical products are occurring with increasing frequency in Europe. Data from the Austrian Agency for Health and Food Safety (AGES) show an increase in Austria from 323 affected pharmaceutical products in 2019 to over 1,500 in 2023.This development is related to structural changes in pharmaceutical production. Over extended periods, manufacturing was increasingly…

In pharmaceutical secondary production, we combine modular technology, flexible processes and structured team leadership to align production structures precisely with varying requirements. We understand variability as a plannable variable within a stable, quality-assured overall system. Our site in Traiskirchen near Vienna was designed from the outset to enable efficient format changes and short changeover times….

Stable pharmaceutical supply in Europe requires high-performance production structures, regulatory expertise and reliable supply chains. Against this backdrop, regional capacities in pharmaceutical manufacturing are gaining increasing importance. Complex Pharmaceuticals has therefore established a new secondary packaging facility near Vienna. Production structures are being created that are designed to supply pharmaceutical products efficiently, flexibly and in…

Reliable supply of pharmaceutical products requires that production, quality and distribution processes are coordinated along the entire value chain. Isolated individual solutions are increasingly reaching their limits, particularly in a regulatory-demanding and time-critical environment.Complex Pharmaceuticals therefore pursues an integrated approach that systematically links manufacturing, secondary packaging and distribution. The aim is to reduce process interfaces,…

What regulation prescribes, where production reaches its limits and how entrepreneurial decisions are meant to strengthen supply security — a look at a new industrial model. Supply shortages of pharmaceutical products are now firmly part of everyday supply reality in Austria and Europe. The current political debate and the high operational burden on pharmacies and…

Supply shortages of pharmaceutical products have triggered a fundamental debate: How much industrial self-reliance does Europe need to permanently secure the supply of medicines to its patients? Christoph Reinwald, General Manager of Complex Pharmaceuticals, and Pia Fischer-Windsteig, Head of Quality Management & PV, on sovereignty, modular production models and the question of why proximity of…

The pharmaceutical industry is facing a paradigm shift: increasing demand volatility and the trend towards personalised and specialised therapies are requiring flexible production structures, while highly standardised, inflexible production structures are increasingly losing their competitive edge. Complex Pharmaceuticals has deliberately pursued a different strategic approach at the Vienna site: a consistently modular production structure with…

Supply shortages of pharmaceutical products are also a reality in Austria, but they do not automatically mean a supply gap. Despite existing restrictions, supply to patients can in most cases still be maintained. Shortages do exist, however, and represent an increasing organisational burden for pharmacies, wholesale distributors and manufacturers. As General Manager of Complex Pharmaceuticals…

The path of a pharmaceutical product from development to the patient is a marathon, not a sprint. Yet often, just before the finish line — at the transition from the clinical phase (investigational medicinal products) to commercial market supply — unnecessary friction losses occur. Many pharmaceutical companies work with specialised small suppliers during the clinical…

A pharmaceutical start-up responds to real shortages on the market — with flexible production, clear leadership and a focus on supply security in Europe. In pharmaceutical production, it is becoming increasingly apparent that existing structures are not suited to all requirements, particularly when flexibility is needed. Complex Pharmaceuticals was founded at the end of 2024…

Shortages of medicines across Europe show that new structures in the pharmaceutical industry are urgently needed. The start-up Complex Pharmaceuticals aims to bring production expertise back to Austria and to strengthen supply security with its state-of-the-art and sustainably oriented production and packaging centre in Traiskirchen near Vienna. What regulation prescribes, where production reaches its limits…

Competition for qualified professionals has long been a strategic factor in the pharmaceutical industry. Highly specialised expertise, regulatory complexity and increasing demands on quality and speed make one thing clear: Employees are the central asset of value creation. Technology, processes and infrastructure are necessary — however, they do not create a sustainable competitive advantage. The…

Why leadership is more than management. The pharmaceutical industry is under massive pressure to change. Regulatory requirements, technological innovations and economic conditions are continuously evolving. Yet while investments in infrastructure and technology frequently take centre stage, one decisive factor is often underestimated: leadership and corporate culture. In this episode of the Inside Complex Pharma podcast,…

Pharma start-up brings fresh momentum to the domestic pharmaceutical industry The young, dynamic pharmaceutical company Complex Pharmaceuticals is now moving forward at full speed. With an experienced management team consisting of Christoph Reinwald, Claudia Turetschek and Pia Fischer-Windsteig at the helm, and with ambitious goals, the company aims to rethink the pharmaceutical value chain and…

New high-tech packaging facility near Vienna strengthens supply security in Europe. Complex Pharmaceuticals is realising a state-of-the-art secondary packaging facility. With the aim of sustainably securing pharmaceutical supply in Europe, the Vienna-based company Complex Pharmaceuticals GmbH is implementing a landmark project: the construction of a state-of-the-art secondary packaging facility covering an area of 7,800 m²…

New high-tech packaging facility near Vienna strengthens supply security in Europe. Location strategy with impact: How Austria is contributing to the future of pharmaceutical supply. Rethinking the pharmaceutical industry: How Austria’s strengths as a location contribute to Europe’s strategic supply sovereignty. Global instability, fragile supply chains and increasing dependence on third countries have mercilessly exposed…

Do you need a partner who combines scalability, validated expertise and tailor-made packaging solutions? Complex Pharmaceuticals specialises in complex requirements — from clinical trial materials through to series production. Find out more about our state-of-the-art infrastructure, efficient project launches and consistently lived quality. This interview was published on top-leader.at

Exclusive interview with Christoph Reinwald, General Manager of Complex Pharmaceuticals GmbH, on the challenges facing Austria as a pharmaceutical location, ensuring domestic pharmaceutical supply, and much more. This article was published on top-leader.at

New medicines. New markets. New expectations. Pharmaceutical packaging is facing a transformation — and Complex Pharmaceuticals provides the fitting answer: with a high-end secondary packaging line that combines technology, sustainability and operational flexibility in one system. A look behind the scenes of a company that is rethinking packaging — and thereby setting new benchmarks. This…